FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
Obere Zahlbacher Str. 63, Geb. 912, 55131 Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Forschungsprojekte
Ergebnisse pro Seite:
10
2022 - 2026
Targeting chromatin complexes to reverse AML immune escape for engineered cell therapy (SFB 1292/2, TP 12)- Dr. Michael,
- Prof. Dr. Evelyn
2022 - 2025
Lebensqualität von Patienten und deren Bettpartnern vor und nach Implantation eines Hypoglossus-Neurostimulators (HGNS)- Prof. Dr. Haralampos
2022 - 2040
A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera (#1418)- Prof. Dr. Markus
2022 - 2026
A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle InvasiveBladder Cancer (VOLGA)- PD Dr. med. Maximilian,
- PD Dr. Rene,
- Dr. Anita
2022 - 2025
Kompatibilität und Stabilität von applikationsfertigen Parenteralia- Prof. Dr. Irene,
- Zoe,
- Dr. Judith
2022 - 2027
Analysis of antibody responses against tumor-derived neo-antigens in triple-negative breast cancer (TNBC)- Univ.-Prof. Dr. Marcus,
- PD Dr. Anne-Sophie